SECOND EXTENSION - GRANTED
granted
on 18 Dec 2024
Last Applicant/ Owned by
530 Fairview Avenue North, Suite 1400
Seattle
WA
98109
Serial Number
97273771 filed on 18th Feb 2022
Registration Number
N/A
Correspondent Address
CONNIE ELLERBACH
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
VISLUCI
Medical research; scientific research; product research and development; product development in the field of the detection, location, and treatment of diseases; design and development of therapies, diagnostic agents, imaging agents, and medical devices for detecting, locating, and treating cancer and other diseases Diagnostic agents, preparations, and substances for medical purposes; Imaging and Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Medical research; scientific research; product research and development; product development in the field of the detection, location, and treatment of diseases; design and development of therapies, diagnostic agents, imaging agents, and medical devices for detecting, locating, and treating cancer and other diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Diagnostic agents, preparations, and substances for medical purposes; Imaging and therapeutic agents for detecting, diagnosing, and treating cancer, oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders; Preparations and substances for medical purposes for detecting, diagnosing, and treating cancer, oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders; None of the foregoing for detecting, diagnosing, or treating diseases originating in the eye, with the exception of melanoma; medical diagnostic reagents; reagents for medical use; imaging and detection agents for diagnosing and monitoring cancer, and oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97273771
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 18th Dec 2024 | SOU EXTENSION 2 GRANTED |
| 18th Dec 2024 | SOU EXTENSION 2 FILED |
| 18th Dec 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 18th Dec 2024 | SOU TEAS EXTENSION RECEIVED |
| 10th Jul 2024 | SOU EXTENSION 1 FILED |
| 10th Jul 2024 | SOU EXTENSION 1 GRANTED |
| 10th Jul 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 10th Jul 2024 | SOU TEAS EXTENSION RECEIVED |
| 30th Jan 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 16th Dec 2023 | TTAB RELEASE CASE TO TRADEMARKS |